首页 › 股票 › XTLB

XTLB — XTL BIOPHARMACEUTICALS LTD

申报持仓市值$293.25K
持有基金数(最新)13
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)3
机构持仓市值$20.65K · 7.57K 股
新建/增持/减仓/清仓1 / 1 / 1 / 4 · 更新于 2026-11-13
前五大/前十大集中度100.0% / 100.0%
机构整体持仓变动 减持 -20.6% (-1.93K 股)
机构持仓市值变动 下降 -10.1%

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 3 家机构在其最新 13F 申报中持有 XTLB(XTL BIOPHARMACEUTICALS LTD),合计申报市值 $20.65K,对应 7.57K 股。按股数计算较上季度减持 20.6%(-1.93K 股),申报市值环比下降 10.1%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。

与上一季度相比,1 家新建仓位、1 家加仓、1 家减仓、4 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

XTL BIOPHARMACEUTICALS LTD(XTLB)的主要机构持有人包括 Noked Israel Ltd、Renaissance Technologies、Citadel Advisors,按 13F 申报市值在本页 13 家持有人中排名居前。

XTLB 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 3 10.73K $25.37K +41.9%
Q2 2026 3 7.57K $20.65K -20.6%
Q1 2026 6 72.70K $175.38K -75.7%
Q4 2025 6 329.73K $190.88K +2.0%
Q3 2025 4 226.92K $265.80K -0.7%
Q2 2025 4 228.50K $261.10K +1.8%
Q1 2025 4 248.30K $298.68K -2.2%
Q4 2024 3 228.19K $462.74K -1.6%

表内 8 个季度中,机构持股合计减少 95%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2026(-75.7%)。

前 25 大机构持仓人(Q3 2026) — 3 家基金

基金股数金额组合权重变化
RHUMBLINE ADVISERS 6.87K $16.49K 0.00% 增持
GAMMA Investing LLC 3.44K $7.90K 0.00% 增持
UBS Group AG 427 $983 0.00% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 3 家基金

基金股数金额组合权重变化
RHUMBLINE ADVISERS 6.23K $17.00K 0.00% 增持
GAMMA Investing LLC 1.21K $3.31K 0.00% 减持
UBS Group AG 125 $341 0.00% 新进

Q1 2026 — 6 家基金

基金股数金额组合权重变化
Noked Israel Ltd 49.72K $120.00K 0.02% 减持
SmartHarvest Portfolios, LLC 13.35K $32.18K 0.01% 新进
RHUMBLINE ADVISERS 5.99K $14.43K 0.00% 减持
GAMMA Investing LLC 3.39K $8.16K 0.00% 减持
Tower Research Capital LLC (TRC) 244 $588 0.00% 新进
Morgan Stanley 10 $24 0.00% 减持

Q4 2025 — 6 家基金

基金股数金额组合权重变化
Noked Israel Ltd 198.89K $115.00K 0.02% 持有
Citadel Advisors 75.87K $44.00K 0.00% 新进
RHUMBLINE ADVISERS 30.11K $17.46K 0.00% 增持
GAMMA Investing LLC 12.89K $7.47K 0.00% 新进
XTX Topco Ltd 10.24K $5.94K 0.00% 新进
Morgan Stanley 1.74K $1.01K 0.00% 减持

Q3 2025 — 4 家基金

基金股数金额组合权重变化
Noked Israel Ltd 198.89K $233.00K 0.04% 持有
RHUMBLINE ADVISERS 17.26K $20.19K 0.00% 持有
Morgan Stanley 10.01K $11.71K 0.00% 减持
UBS Group AG 763 $893 0.00% 减持

Q2 2025 — 4 家基金

基金股数金额组合权重变化
Noked Israel Ltd 198.89K $227.00K 0.04% 持有
RHUMBLINE ADVISERS 17.26K $20.02K 0.00% 增持
Morgan Stanley 11.01K $12.55K 0.00% 减持
UBS Group AG 1.34K $1.52K 0.00% 新进

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 13 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
RHUMBLINE ADVISERS 6.87K 6.23K 5.99K 30.11K 17.26K 17.26K 10.95K 10.95K 6.52K 5.58K — — — — — — — — — —
GAMMA Investing LLC 3.44K 1.21K 3.39K 12.89K — — — — — — — — — — — — — — — —
UBS Group AG 427 125 — — 763 1.34K — — — — 6.95K 54 120 — — 300 — — 812 154
Noked Israel Ltd — — 49.72K 198.89K 198.89K 198.89K 198.89K 198.89K 198.89K 198.89K 198.89K 198.89K 198.89K — — — — — — —
Morgan Stanley — — 10 1.74K 10.01K 11.01K 13.25K 18.35K 26.45K 33.15K 39.17K 39.77K 40.57K 41.17K 41.77K 42.97K 45.27K 48.77K 49.27K 51.07K
Renaissance Technologies — — — — — — — — — — — — — — — — — — — 23.28K
Citadel Advisors — — — 75.87K — — 25.21K — — 15.44K 13.63K — — — — — — — — —
SmartHarvest Portfolios, LLC — — 13.35K — — — — — — — — — — — — — — — — —
XTX Topco Ltd — — — 10.24K — — — — — — — — — — — — — — — —
BNP PARIBAS FINANCIAL MARKETS — — — — — — — — — — 300 300 300 — — — — — — —
Tower Research Capital LLC (TRC) — — 244 — — — — — — — — — — — — — — — — —
CENTRAL TRUST Co — — — — — — — — — — — 200 — — — — — — — —
GROUP ONE TRADING LLC — — — — — — — — — — — — 100 — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold XTLB?

As of 2026-Q2, 3 institutional funds reported holding XTLB (XTL BIOPHARMACEUTICALS LTD) in SEC 13F filings, with a combined reported value of $20.65K.

How many shares of XTLB do institutions own?

13F filers reported 7.57K shares of XTLB, worth $20.65K in aggregate at the end of 2026-Q2.

Is institutional ownership of XTLB rising or falling?

Share counts moved -20.6% versus the prior quarter — distribution.

Who are the top institutional holders of XTLB?

The largest 13F holders are Noked Israel Ltd, Renaissance Technologies, Citadel Advisors, SmartHarvest Portfolios, LLC, RHUMBLINE ADVISERS; the top 25 are ranked at the top of this page.

Who are the major shareholders of XTL BIOPHARMACEUTICALS LTD?

The major shareholders of XTL BIOPHARMACEUTICALS LTD (XTLB) by reported 13F value are Noked Israel Ltd, Renaissance Technologies, Citadel Advisors, SmartHarvest Portfolios, LLC, RHUMBLINE ADVISERS, among 13 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 XTLB」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/XTLB/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →